RefleXion Medical is set to unveil its game-changing RefleXion X1 with SCINTIX biology-guided radiotherapy at the ASTRO 2023 Annual Meeting in San Diego, BOOTH #2831. A robust lineup of 19 scientific presentations by researchers from various clinical programs will validate the efficacy of SCINTIX therapy through the X1 platform. These findings highlight breakthrough precision, successful first-in-human trials, and error mitigation in IMRT/SBRT treatment planning. Dr. Shervin “Sean” Shirvani, Chief Medical Officer at RefleXion, anticipates the event as patient treatments commence across the U.S.
RefleXion Medical is set to make waves at the upcoming American Society for Radiation Oncology (ASTRO) Annual Meeting, taking place from October 1st to 4th, 2023, in San Diego at BOOTH #2831. The company is gearing up to unveil its groundbreaking RefleXion X1, featuring the revolutionary SCINTIX biology-guided radiotherapy.
A remarkable total of 19 scientific presentations will be on display, presenting compelling data that solidifies the effectiveness of SCINTIX therapy. These presentations will encompass a range of formats, including oral presentations and featured posters, and will be delivered by researchers from various clinical programs. Their collective findings strongly endorse the efficacy and viability of SCINTIX therapy, as exclusively administered through the X1 platform.
Dr. Shervin “Sean” Shirvani, Chief Medical Officer at RefleXion, expressed his excitement, stating, “We are elated to witness the burgeoning body of evidence that substantiates the value of SCINTIX therapy, particularly as we initiate patient treatments at multiple sites across the United States.” Dr. Shirvani went on to emphasize the pivotal nature of these presentations, underlining their ability to showcase the breakthrough precision achieved in addressing multiple moving targets within a single treatment session. Additionally, they will shed light on the outcomes of successful first-in-human trials and elucidate the strategies for mitigating treatment planning errors associated with IMRT/SBRT through the innovative X1 platform with SCINTIX technology.
The forthcoming ASTRO 2023 event promises a dynamic array of oral and featured poster presentations, all centered around the evaluation of the RefleXion X1 machine enhanced with SCINTIX technology. For further insights, additional poster presentations and comprehensive details can be accessed through the provided link.